Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$9.1 million.

  • Icu Medical's Change in Accured Expenses fell 388744.77% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.7 million, marking a year-over-year decrease of 27356.84%. This contributed to the annual value of $20.7 million for FY2024, which is 24274.47% up from last year.
  • Latest data reveals that Icu Medical reported Change in Accured Expenses of -$9.1 million as of Q3 2025, which was down 388744.77% from $16.5 million recorded in Q2 2025.
  • Icu Medical's Change in Accured Expenses' 5-year high stood at $36.7 million during Q2 2024, with a 5-year trough of -$36.3 million in Q1 2025.
  • Over the past 5 years, Icu Medical's median Change in Accured Expenses value was -$4.6 million (recorded in 2022), while the average stood at -$3.8 million.
  • Data for Icu Medical's Change in Accured Expenses shows a peak YoY increase of 26959.3% (in 2021) and a maximum YoY decrease of 439354.84% (in 2021) over the last 5 years.
  • Over the past 5 years, Icu Medical's Change in Accured Expenses (Quarter) stood at $14.6 million in 2021, then tumbled by 221.87% to -$17.8 million in 2022, then soared by 77.78% to -$3.9 million in 2023, then soared by 104.66% to $184000.0 in 2024, then tumbled by 5019.57% to -$9.1 million in 2025.
  • Its Change in Accured Expenses stands at -$9.1 million for Q3 2025, versus $16.5 million for Q2 2025 and -$36.3 million for Q1 2025.